75N91025C00001↗
Azenta US Inc received this contract from Nih Nci, National Institutes of Health: $14.26M obligated so far for reference laboratory testing. It runs to 2027-07-31, or to 2029-12-02 if every option is exercised.
Key facts · data as of Oct 25, 2026
- Recipient
- Azenta US Inc
- Awarding agency
- National Institutes of Health (Department of Health and Human Services)
- Contracting office
- Nih Nci (75N910)
- Obligated to date
- $14.26M
- Potential value
- $35.02M
- Ends
- 2027-07-31
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 25, 2026.
Cite this page: SpendQuery, Award 75N91025C00001, data as of Oct 25, 2026, https://spendquery.com/award?id=CONT_AWD_75N91025C00001_7529_-NONE-_-NONE-
Azenta US Inc: all federal awards · Department of Health and Human Services: spending · Nih Nci: what it buys · The follow-on: recompete brief
A NEW AWARD TO SUPPORT THE RESEARCH MOLECULAR CHARACTERIZATION GOALS OF THE CHILDHOOD CANCER DATA INITIATIVE (CCDI) TO IMPROVE DIAGNOSIS AND TREATMENT FOR CHILDHOOD AND ADOLESCENT AND YOUNG ADULT (AYA) CANCERS.
Up for re-bid: ends 2027-07-31. Recompete brief →
What it is
- Product or service
- Reference Laboratory Testing (PSC Q301)
- Industry
- Testing Laboratories and Services (NAICS 541380)
- Contracting office
- Nih Nci (75N910)
- Competition
- Full and open competition · 2 offers received
- Pricing
- Firm fixed price
- How it was bought
- Standalone contract
- Solicitation
- 75N91023R00042
- Where the work is
- Middlesex, NJ · district NJ-06
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
Every action
3 actions since 2024-12-02. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-07-24 | P00002 | Option exercised | $6.98M | EO 14398 SUPPORTS THE RESEARCH MOLECULAR CHARACTERIZATION GOALS OF THE CHILDHOOD CANCER DATA INITIATIVE (CCDI) TO IMPROVE DIAGNOSIS AND TREATMENT FOR CHILDHOOD AND ADOLESCENT AND YOUNG ADULT (AYA) CANCERS. |
| 2025-05-30 | P00001 | Option exercised | $4.09M | SUPPORTS THE RESEARCH MOLECULAR CHARACTERIZATION GOALS OF THE CHILDHOOD CANCER DATA INITIATIVE (CCDI) TO IMPROVE DIAGNOSIS AND TREATMENT FOR CHILDHOOD AND ADOLESCENT AND YOUNG ADULT (AYA) CANCERS. |
| 2024-12-02 | 0 | $3.19M | A NEW AWARD TO SUPPORT THE RESEARCH MOLECULAR CHARACTERIZATION GOALS OF THE CHILDHOOD CANCER DATA INITIATIVE (CCDI) TO IMPROVE DIAGNOSIS AND TREATMENT FOR CHILDHOOD AND ADOLESCENT AND YOUNG ADULT (AYA) CANCERS. |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-25). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗